Page last updated: 2024-11-03

prazosin and Weight Loss

prazosin has been researched along with Weight Loss in 1 studies

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Weight Loss: Decrease in existing BODY WEIGHT.

Research Excerpts

ExcerptRelevanceReference
"Morphine tolerance was induced using a 3-day cumulative twice-daily dosing regimen with s."1.32Influence of prazosin and clonidine on morphine analgesia, tolerance and withdrawal in mice. ( Lähdesmäki, J; Ozdoğan, UK; Scheinin, M, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ozdoğan, UK1
Lähdesmäki, J1
Scheinin, M1

Other Studies

1 other study available for prazosin and Weight Loss

ArticleYear
Influence of prazosin and clonidine on morphine analgesia, tolerance and withdrawal in mice.
    European journal of pharmacology, 2003, Jan-24, Volume: 460, Issue:2-3

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Analgesics, Opioid; Animals; Behavior, Anim

2003